Robotic Sterile Fill-Finish Services

At PCI, ensuring life-changing medicines reach those who need it most is our highest priority. As a truly integrated global CDMO, we are manufacturing, packaging and supply chain experts, harnessing our experience and expertise to deliver you a seamless solution with the ultimate aim of improving the lives of patients.

To complement our existing sterile fill-finish capabilities, we have further invested in state-of-the-art robotic technology. This investment comprises two Cytiva Microcell Vial Filler units for earlier clinical scale manufacture and a larger scale Cytiva SA25 Aseptic Filling Workstation for later stage clinical through to commercial launch scale manufacture.

The scalability of our robotic service offering from the Microcell Vial Filler through to the larger SA25 Filling Workstation allows us to plan for delivery of larger clinical and commercial scale production as a product moves through its life-cycle. In addition, as the SA25 technology is able to fill multiple delivery device formats including vials, syringes, and cartridges, we will work with you throughout the early clinical development program to offer a seamless later stage clinical and commercial scale production plan in the most patient-centric delivery format.

Our dedicated team of specialists will be happy to discuss any of your Robotic Sterile Fill-Finish Service needs. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com

Robotic Sterile Fill-Finish Services - Download this info sheet

Contact Us. Let's talk future.

Rely on our robotic sterile fill-finish services to expedite your drug product journey.

Accelerating your product through development to commercialization and beyond.

Harnessing decades of global drug product development and commercialization experience, you can rely on our integrated speed solutions to simplify your supply chain, spanning the cycle from study to launch.

talkfuture@pci.com

Spanning the cycle.A truly global proposition.

Always growing, we are driving development and connecting commercialization, and with 4300 people in 30 global GMP facilities, we are always close.